Stock Earnings

Question 1

How did CRSP's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for CRISPR Therapeutics AG is $-1.28, beating expectations of $-1.24.

Question 2

How did CRISPR Therapeutics AG CRSP's revenue perform in the last quarter?

Accepted Answer

CRISPR Therapeutics AG revenue for the last quarter is $-1.28

Question 3

What is the revenue estimate for CRISPR Therapeutics AG?

Accepted Answer

According to 19 of Wall street analyst, the revenue estimate of CRISPR Therapeutics AG range from $37.69M to $0.0

Question 4

What's the earning quality score for CRISPR Therapeutics AG?

Accepted Answer

CRISPR Therapeutics AG has a earning quality score of B+/54.822727. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does CRISPR Therapeutics AG report earnings?

Accepted Answer

CRISPR Therapeutics AG next earnings report is expected in 2026-08-02

Question 6

What are CRISPR Therapeutics AG's expected earnings?

Accepted Answer

CRISPR Therapeutics AG expected earnings is $2.75M, according to wall-street analysts.

Question 7

Did CRISPR Therapeutics AG beat earnings expectations?

Accepted Answer

CRISPR Therapeutics AG recent earnings of $1.45M does not beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$-1.24	$-1.28	+3.22%	BEAT
Q4 '25	$-1.17	$-1.37	+17.09%	BEAT
Q3 '25	$-1.28	$-1.17	-8.59%	MISSED
Q2 '25	$-1.45	$-1.29	-11.03%	MISSED
Q1 '25	$-1.27	$-1.58	+24.4%	BEAT

CRISPR Therapeutics AG (CRSP) Price

CRSP Stock Price Chart

Latest Earnings Results: Q1 '26

Historical Earnings

Earnings FAQ